BIOGRAPHY
Dr. Tsai is Vice Chair, Research and Translational Pathology at the H. Lee Moffitt Cancer Center & Research Institute, where he oversees institutional research and the deployment of computational pathology. He is a physician-scientist overseeing a translational skin cancer research laboratory focused on aggressive skin carcinomas. He also maintains a dermatology and dermatopathology practice.
SESSIONS
DISCLOSURES
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); Ankyra Therapeutics – Independent Contractor(Grants/Research Funding); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);